MPLT vs NTRS · $1.24B cap vs P/E 18, rev $2.69B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
MPLT does not have a complete income-statement cache yet.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
MPLT currently screens at market cap $1.24B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the MPLT and NTRS stock pages for the full models.
Not investment advice.